Last reviewed · How we verify

NCT06901323

Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With Phenylketonuria

Active, enrolled Phase 4 Last updated 4 April 2025
What this trial tests

Phase 4 trial testing L-carnitine in Phenylketonuria in 176 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 February 2025
Primary endpoint
1 March 2026
1 August 2026

Quick facts

Lead sponsorMansoura University
PhasePhase 4
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingnone
Primary purposesupportive care
Enrollment176
Start date1 February 2025
Primary completion1 March 2026
Estimated completion1 August 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

Adults 1 Month to 18, any sex, with Phenylketonuria. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Effect of L-carnitine supplementation on phenylalanine and brain-derived neurotrophic factor levels in infants and children with phenylketonuria L-carnitine is mainly obtained from foods such as red meat and milk that are limited for PKU patients due to dietary protein restriction. So, L-carnitine deficiency has been described in phenylketonuric patients The aim of this study is to : 1. Compare level of Brain-derived neurotrophic factor in infants and children with phenylketonuria and healthy infants and children. 2. Compare level of phenylalanine and Brain-derived neurotrophic factor before and after L-carnitine supplementation in phenylketonuric patients. 3. Assess Intelligence quotient test before and after L-carnitine supplementation in phenylketonuric patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of L-carnitine

Trials testing the same drug.

Other recruiting trials for Phenylketonuria

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06901323.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing